• ProLogium filed an initial Form F-4 with the SEC on July 6, 2026, advancing its planned merger with Translational Development Acquisition Corp.
• The filing provides expanded background on ProLogium and additional information on the deal announced May 27, 2026.
• The registration statement remains subject to SEC review and potential revisions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Translational Development Acquisition Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-081579), on July 08, 2026, and is solely responsible for the information contained therein.